OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/08/2026
Back to search
Official data from USPTO
LIBELULA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LIBELULA
ST13
US500000079400586Class
5, 41, 42
Filing
79400586
Registration
7734564
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 41, 42
Filing date
04/17/2024
Registration date
03/25/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/25/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CH
Examiner
SEVERSON, JUSTIN
Law office
M20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Debiopharm International SA
Representatives
Duane M. Byers Nixon & Vanderhye PC
Technical classification
Nice Classes
Class 5Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products focused on endocrinologymedical preparations for the treatment of precocious puberty and for participants receiving gonadotropin releasing hormone agonist therapy for central precocious puberty
Class 41
Publication of clinical trial results in the field of endocrinology
Class 42
Providing medical and scientific research information in the field of pharmaceutical products; carrying out clinical trials for pharmaceutical products; scientific research for medical purposes in the field of endocrinology
Publications
History of USPTO decisions and trademark events.
25 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/24/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/24/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/24/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/08/2025
FIMP
FINAL DISPOSITION PROCESSED
10/08/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/26/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/25/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
03/25/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/04/2025
PUBO
PUBLISHED FOR OPPOSITION
02/04/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/29/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/09/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/31/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/31/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/31/2024
RFNT
REFUSAL PROCESSED BY IB
11/30/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/14/2024
RFRR
REFUSAL PROCESSED BY MPU
11/14/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/08/2024
CNRT
NON-FINAL ACTION WRITTEN
11/06/2024
DOCK
ASSIGNED TO EXAMINER
10/30/2024
MAFR
APPLICATION FILING RECEIPT MAILED
07/29/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/29/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/25/2024
Continuous trademark protection
Get notified about every new filing that threatens LIBELULA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.